NCT05057013 2025-08-11
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
Phase 1/2 Active not recruiting
Cancer Research UK
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes